YIH
LNAI

Y-Intercept (HK)’s Lunai Bioworks LNAI Stock Holding History

Y-Intercept (HK)’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-181
Closed -$4.19K – 1959
2025
Q2 		$4.19K Buy
+181
New +$5.05K ﹤0.01% 1587
2024
Q4 		– Sell
-155
Closed -$5.98K – 1577
2024
Q3 		$5.98K Buy
+155
New +$10.7K ﹤0.01% 1237
2024
Q2 		– Sell
-526
Closed -$111K – 1837
2024
Q1 		$111K Buy
526
+295
+128% +$79.6K 0.01% 1269
2023
Q4 		$58.6K Buy
+231
New +$63.3K 0.01% 1144
2023
Q3 		– Sell
-540
Closed -$24.5K – 1501
2023
Q2 		$24.5K Buy
+540
New +$41.4K ﹤0.01% 1214

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return